JP2002515487A5 - - Google Patents

Download PDF

Info

Publication number
JP2002515487A5
JP2002515487A5 JP2000549591A JP2000549591A JP2002515487A5 JP 2002515487 A5 JP2002515487 A5 JP 2002515487A5 JP 2000549591 A JP2000549591 A JP 2000549591A JP 2000549591 A JP2000549591 A JP 2000549591A JP 2002515487 A5 JP2002515487 A5 JP 2002515487A5
Authority
JP
Japan
Prior art keywords
group
hydrogen
compound according
compound
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000549591A
Other languages
English (en)
Japanese (ja)
Other versions
JP4132671B2 (ja
JP2002515487A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/009450 external-priority patent/WO1999059972A1/en
Publication of JP2002515487A publication Critical patent/JP2002515487A/ja
Publication of JP2002515487A5 publication Critical patent/JP2002515487A5/ja
Application granted granted Critical
Publication of JP4132671B2 publication Critical patent/JP4132671B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000549591A 1998-05-15 1999-04-30 タキキニン受容体アンタゴニストとしてのカルボキシ置換カルボキサミド誘導体 Expired - Lifetime JP4132671B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7961098A 1998-05-15 1998-05-15
US09/079,610 1998-05-15
PCT/US1999/009450 WO1999059972A1 (en) 1998-05-15 1999-04-30 Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists

Publications (3)

Publication Number Publication Date
JP2002515487A JP2002515487A (ja) 2002-05-28
JP2002515487A5 true JP2002515487A5 (enExample) 2006-01-05
JP4132671B2 JP4132671B2 (ja) 2008-08-13

Family

ID=22151630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000549591A Expired - Lifetime JP4132671B2 (ja) 1998-05-15 1999-04-30 タキキニン受容体アンタゴニストとしてのカルボキシ置換カルボキサミド誘導体

Country Status (20)

Country Link
EP (1) EP1077942B1 (enExample)
JP (1) JP4132671B2 (enExample)
KR (1) KR20010043598A (enExample)
CN (1) CN1136191C (enExample)
AR (1) AR015298A1 (enExample)
AT (1) ATE286882T1 (enExample)
AU (1) AU743487B2 (enExample)
DE (1) DE69923173T2 (enExample)
DK (1) DK200001669A (enExample)
ES (1) ES2233042T3 (enExample)
HU (1) HUP0102531A3 (enExample)
IL (1) IL139262A (enExample)
MX (1) MXPA00011204A (enExample)
NO (1) NO319766B1 (enExample)
NZ (1) NZ507432A (enExample)
PT (1) PT1077942E (enExample)
SI (1) SI1077942T1 (enExample)
TW (1) TWI228122B (enExample)
WO (1) WO1999059972A1 (enExample)
ZA (1) ZA200006606B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082421A1 (en) * 2000-09-14 2002-06-27 Abdel-Magid Ahmed F. Novel solid salt forms of N-[2-[4-[2-(1- methylethoxy)phenyl]-1-piperazinyl]-2-oxo-1piperidineacetamide
US20060128752A1 (en) * 2002-07-03 2006-06-15 Giuseppe Alvaro Chemical compounds
US8093268B2 (en) 2007-01-24 2012-01-10 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502644D0 (en) * 1995-02-10 1995-03-29 Zeneca Ltd Heterocyclic derivatives
FR2738245B1 (fr) * 1995-08-28 1997-11-21 Sanofi Sa Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant

Similar Documents

Publication Publication Date Title
JP2004521087A5 (enExample)
JP2002543185A5 (enExample)
JP2010540525A5 (enExample)
RU2003136097A (ru) Производные фенилпиридинкарбонилпиперазина
JP2006524225A5 (enExample)
JP2003528918A5 (enExample)
JP2003520235A5 (enExample)
JP2002520316A5 (enExample)
JP2002540208A5 (enExample)
JP2009534471A5 (enExample)
CA2389306A1 (en) Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
JP2004524316A5 (enExample)
JP2007231005A5 (enExample)
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
JP2002030084A5 (enExample)
JP2005536519A5 (enExample)
RU2003115612A (ru) Производные амидоалкилпиперидинов и амидоалкилпиперазинов, пригодные для лечения нарушений нервной системы
JP2011500694A5 (enExample)
JP2010526801A5 (enExample)
JP2005527542A5 (enExample)
JP2013506674A5 (enExample)
JP2002506864A5 (enExample)
JP2003507380A5 (enExample)
JP2004315496A5 (enExample)
JP2005526773A5 (enExample)